(Q35162231)

6 August 2017

1 reference

title

1,4-Dihydropyridines as calcium channel ligands and privileged structures (English)

1 reference

6 August 2017

David J Triggle

1

1 reference

6 August 2017

1 June 2003

1 reference

Cellular and Molecular Neurobiology

6 August 2017

1 reference

6 August 2017

23

1 reference

6 August 2017

293-303

1 reference

6 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1023632419813

6 August 2017

0 references

cites work

Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor

1 reference

12 December 2020

Target-oriented and diversity-oriented organic synthesis in drug discovery

1 reference

12 December 2020

The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons.

1 reference

12 December 2020

Speciation of cone snails and interspecific hyperdivergence of their venom peptides. Potential evolutionary significance of introns

1 reference

12 December 2020

The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.

1 reference

12 December 2020

Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists

1 reference

12 December 2020

Structural basis of drug binding to L Ca2+ channels

1 reference

12 December 2020

Conopeptides: From deadly venoms to novel therapeutics

1 reference

12 December 2020

Calcium antagonists. History and perspective

1 reference

12 December 2020

Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties

1 reference

12 December 2020

1,4-Dihydropyridines--a basis for developing new drugs

1 reference

12 December 2020

The coronary vasodilator action of khellin

1 reference

12 December 2020

Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188.

1 reference

12 December 2020

Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists

1 reference

12 December 2020

The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits

1 reference

12 December 2020

The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines

1 reference

12 December 2020

4-Alkyl-1,4-dihydropyridines derivatives as specific PAF-acether antagonists

1 reference

12 December 2020

Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human alpha1C subunit gene

1 reference

12 December 2020

Medicinal Chemistry: Challenges and Opportunities

1 reference

12 December 2020

Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity

1 reference

12 December 2020

Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.

1 reference

12 December 2020

K-channel opening activity of dihydropyridine ZM244085: effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle.

1 reference

12 December 2020

Molecular determinants of drug binding and action on L-type calcium channels

1 reference

12 December 2020

Dihydropyridine neuropeptide Y Y(1) receptor antagonists

1 reference

12 December 2020

Phenylalanine in the second membrane-spanning domain of alpha 1A-adrenergic receptor determines subtype selectivity of dihydropyridine antagonists

1 reference

12 December 2020

Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes

1 reference

12 December 2020

Ca2+ channel ligands: structure-function relationships of the 1,4-dihydropyridines

1 reference

12 December 2020

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

1 reference

12 December 2020

The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels

1 reference

12 December 2020

Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.

1 reference

12 December 2020

Thirty years of discovering arthropod alkaloids in amphibian skin

1 reference

12 December 2020

Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors

1 reference

12 December 2020

State- and isoform-dependent interaction of isradipine with the alpha1C L-type calcium channel

1 reference

12 December 2020

Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines

1 reference

12 December 2020

Structure and function of voltage-gated ion channels

1 reference

12 December 2020

Effects of Ca2+ channel ligands on [3H]QNB binding at m1 and m3 muscarinic receptors

1 reference

12 December 2020

Cardiovascular effects of YM430, a 1,4-dihydropyridine derivative with beta-adrenoceptor blocking activity, in dogs and rats

1 reference

12 December 2020

Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo

1 reference

12 December 2020

Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.

1 reference

12 December 2020

The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions

1 reference

12 December 2020

Peptidomimetics derived from natural products

1 reference

12 December 2020

Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies

1 reference

12 December 2020

Synthesis and activity of 1,4-dihydropyridine analogues of histamine H2-receptor antagonists

1 reference

12 December 2020

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023632419813

1 reference

PubMed ID

12825828

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12825828